logo-loader
viewOptiBiotix Health PLC

Optibiotix Health makes strong start to 2020 with new product launches and agreements

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive London's Andrew Scott following their recent deal with Granja Pocha S.A.for the inclusion of ProBiotix's patented probiotic strain LPLDL into a functional yogurt product in Uruguay, South America.

O'Hara also recaps on what was a busy January for them with three product launches as well as discusses latest developments with SweetBiotix®.

Quick facts: OptiBiotix Health PLC

Price: 64.5 GBX

AIM:OPTI
Market: AIM
Market Cap: £55.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health agrees exclusive deal for LPLDL in USA and Canada

Steve Prescott, the chief executive of ProBiotix, which is a wholly-owned subsidiary of OptiBiotix Health PLC (LON:OPTI), caught up for a brief chat with Proactive London's Andrew Scott after announcing they've signed a distributor agreement with Advanced NutriSolutions Inc./Select Ingredient...

2 days, 12 hours ago

2 min read